Tag: ContraVir Pharmaceuticals

June 21, 2019

ContraVir Pharmaceuticals Receives FDA Response to CRV431

ContraVir Pharmaceuticals (NASDAQ:CTRV) has announced that the US Food and Drug Administration (FDA) has responded positively to the company’s pre-investigational...